Evidence map›Paper›PMID 35971100›Full record

Observational studyBMC cancer2022

Long-term follow-up on HIV infected and non-infected women with cervical cancer from Tanzania: staging, access to cancer-directed therapies and associated survival in a real-life remote setting.

Laura Glasmeyer, Ruby Doryn Mcharo, Liset Torres, Tessa Lennemann, Elizabeth Danstan, Nice Mwinuka, Mona Judick, William Mueller, Wilbert Mbuya, Michael Hölscher and 4 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Laura GlasmeyerDivision of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU), Munich, Germany.
Ruby Doryn McharoMbeya Medical Research Center (MMRC), National Institute for Medical Research (NIMR), Mbeya, Tanzania.
Liset TorresDepartment of Obstetrics and Gynaecology, Mbeya Zonal Referral Hospital, Mbeya, Tanzania.
Tessa LennemannDivision of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU), Munich, Germany.
Elizabeth DanstanMbeya Medical Research Center (MMRC), National Institute for Medical Research (NIMR), Mbeya, Tanzania.
Nice MwinukaMbeya Medical Research Center (MMRC), National Institute for Medical Research (NIMR), Mbeya, Tanzania.
Mona JudickDivision of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU), Munich, Germany.
William MuellerDepartment of Obstetrics and Gynaecology, Mbeya Zonal Referral Hospital, Mbeya, Tanzania.
Wilbert MbuyaMbeya Medical Research Center (MMRC), National Institute for Medical Research (NIMR), Mbeya, Tanzania.
Michael HölscherDivision of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU), Munich, Germany.
Ralph LelléDivision of Gynecology, University of Muenster, Muenster, Germany.
Christof GeldmacherDivision of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU), Munich, Germany.
Arne Kroidl *Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU), Munich, Germany.
John Rwegoshora France *Department of Obstetrics and Gynaecology, Mbeya Zonal Referral Hospital, Mbeya, Tanzania. rwegoshorafrance@gmail.com.
National Institute for Medical Research · TZLudwig-Maximilians-Universität München · DEMbeya University of Science and Technology · TZCharité - Universitätsmedizin Berlin · DEGerman Center for Infection Research · DEUniversity of Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWorldwide 85% of cervical cancer (CC) related deaths occur in low- and middle-income countries. Sub-Saharan Africa is burdend by an overlapping high incidence of CC as well as HIV infection, a risk factor for HPV associated disease progression. Recent upscaling of CC screening activities increased the number of CC diagnoses in a previous unscreened population. The aim of the 2H study was to follow up on women with CC in the context of available health care services in Tanzania in relation to their HIV infection status.

methodsThis longitudinal observational cohort study included women with histological confirmed CC from Mbeya, Tanzania, between 2013-2019. All women were referred for CC staging and cancer-directed therapies (CDT), including surgery and/or radio-chemotherapy, or palliative care. Annual follow-up focused on successful linkage to CDT, interventions and survival. We assessed factors on compliance, used Kaplan-Meier-Survivor functions to evaluate survival time and poisson regression models to calculate incidence rate ratios on mortality (IRR) two years after diagnosis.

resultsOverall, 270 women with CC (123 HIV infected) were included. Staging information, available in 185 cases, showed 84.9% presented with advanced stage disease (FIGO ≥ IIB), no difference was seen in respect to HIV status. HIV-infected women were 12 years younger at the time of cancer diagnosis (median age 44.8 versus 56.4 years, p < 0.001). Median follow up period was 11.9 months (range 0.2-67.2). Survival information, available in 231 cases, demonstrated for women diagnosed in early-stage disease a median survival time of 38.3 months, in advanced-stage 16.0 months and late-stage disease 6.5 months after diagnosis. Of all women, 42% received CDT or palliative support. HIV co-infection and education were associated with higher health care compliance. CDT was significantly associated with lower 2-year mortality rates (IRR 0.62, p = 0.004). HIV coinfection did not impact mortality rates after diagnosis.

conclusionHigh numbers of advanced and late staged CC were diagnosed, compliance to CDT was low. A beneficial impact of CDT on CC mortality could be demonstrated for local health care services. This study indicates challenges for successful linkage and supports an effective scale up of cancer care and treatment facilities.

Indexed as

HIV InfectionsUterine Cervical NeoplasmsAdultFemaleFollow-Up StudiesHealth Services AccessibilityHumansTanzaniaCancer-directed therapy (CDT)Cancer screeningCervical cancerFIGO stagingHIVMortalityTanzania

Identifiers

PMID35971100
PMCPMC9377112
OpenAlexW4291493248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.